7 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... and Cervical Cancer ... , and sexually active ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... in HIV-AIDS Preventing ... ., concomitant medications ... intraocular levels of drug ... #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infectionPulmonary ... drug use • Silicosis ... Lymphoma • Lung cancer ... • HIV: 2/3 pulmonary ... Tuberculosis Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infectionPulmonary ... drug use • Silicosis ... Lymphoma • Lung cancer ... • HIV: 2/3 pulmonary ... Tuberculosis Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... prevent TB disease) Indications ... no evidence of active ... Tuberculosis #TB #IDSA ... #HIVAIDS #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Lymphadenitis, pulmonary ... lymphadenitis, pulmonary ... keratitis, iritis • CMV ... • Persistently active ... infection/drug
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Note: Active TB ... #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology